Identity
MatchedRetention time + UV spectral comparison
COMPOUND IQRESEARCH. TESTED. EXPLAINED.Scan your COADOCUMENT REVIEW · AUGUST 2026
Skye Peptides BPC-157: three-vial content data, but an aging public report.
We reviewed TrustPointe Analytics test reference 2408090 for three BPC-157 20 mg vials, analyzed August 31, 2024.
Compound IQ has no affiliate relationship with Skye Peptides. We did not purchase or independently test these vials. This score reviews one supplier-hosted public certificate and does not rate current inventory.
WHAT THE CERTIFICATE REPORTS
4 of 7 evidence categories documented.
The TrustPointe certificate reports three-vial HPLC results for identity, purity, and measured content, plus system-suitability controls. Reference: 2408090 · SAMPLE BPC24-20-001.
Purity
99.33–99.61%TM-1003 HPLC across three vialsMeasured quantity
19.04–19.11 mgHPLC vial-content results across three vialsLot traceability
BPC24-20-001Client sample ID + test reference 2408090Sterility
Not reportedNo sterility or microbial result in this certificateEndotoxin
Not reportedNo quantitative endotoxin result or methodContaminants
Not reportedNo heavy-metal, solvent, or other contaminant panelThe three reported vial-content results average about 19.07 mg—roughly 4.7% below the 20 mg description. The certificate does not assign a content pass/fail specification.
WHAT THE HEADLINE DOES NOT SAY
Four limits that belong beside the score.
The report is from 2024
A technically detailed certificate can still become less relevant to current inventory over time. The public document does not establish what lot is being sold in August 2026.
Sample traceability is not a retail-lot match
The certificate includes a client sample ID and test reference, while the lot field reads “BPC 20mg 3 vials.” A buyer would still need to match a current vial to a current lot-specific report.
Identity is HPLC-based
Retention-time and UV-spectrum comparison are useful identity evidence, but this report does not show a mass-spectrometry confirmation of molecular mass.
Three evidence categories are missing
This certificate does not report sterility, endotoxin, heavy metals, residual solvents, or another contaminant screen for the tested vials.
COMPOUND IQ VERDICT
Good analytical detail for the tested vials. Weak current-lot relevance.
The three replicate content and purity results are more informative than a purity-only COA, and the certificate includes method controls. Its age and limited link to current inventory are the central weaknesses. Current buyers should request a current lot-matched report rather than treating this 2024 document as evergreen evidence.
SOURCE DOCUMENTS
Inspect the evidence directly.
Read the original certificate, match any current vial to its exact lot, and do not extend this result to another batch or product.